Treatment pathway of bone sarcoma in children, adolescents, and young adults

Author:

Reed Damon R.123ORCID,Hayashi Masanori4,Wagner Lars5,Binitie Odion136,Steppan Diana A.4,Brohl Andrew S.12,Shinohara Eric T.7,Bridge Julia A.8,Loeb David M.4,Borinstein Scott C.9ORCID,Isakoff Michael S.10

Affiliation:

1. Sarcoma Department; H. Lee Moffitt Cancer Center and Research Institute; Tampa Florida

2. Chemical Biology and Molecular Medicine Program, H. Lee Moffitt Cancer Center and Research Institute; Tampa Florida

3. Adolescent and Young Adult Program, H. Lee Moffitt Cancer Center and Research Institute; Tampa Florida

4. Division of Pediatric Oncology, Department of Oncology, Sidney Kimmel Comprehensive Cancer Center; Johns Hopkins University; Baltimore Maryland

5. Division of Pediatric Hematology/Oncology; University of Kentucky; Lexington Kentucky

6. Department of Orthopedic Surgery; University of South Florida College of Medicine; Tampa Florida

7. Department of Radiation Oncology; Vanderbilt University Medical Center; Nashville Tennessee

8. Department of Pathology and Microbiology; University of Nebraska Medical Center, Nebraska Medical Center; Omaha Nebraska

9. Division of Pediatric Hematology-Oncology, Department of Pediatrics; Vanderbilt University Medical Center; Nashville Tennessee

10. Center for Cancer and Blood Disorders, Connecticut Children's Medical Center; Hartford Connecticut

Funder

National Pediatric Cancer Foundation

SARC Sarcoma SPORE Career Development Award

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference55 articles.

1. National Comprehensive Cancer Network NCCN guidelines for treatment of cancer by site: bone cancer (version 2.2017) https://www.nccn.org/professionals/physician_gls/f_guidelines.asp

2. Adjuvant chemotherapy of high-grade osteosarcoma of the extremity. Updated results of the Multi-Institutional Osteosarcoma Study;Link;Clin Orthop Relat Res.,1991

3. Osteosarcoma: current treatment and a collaborative pathway to success;Isakoff;J Clin Oncol.,2015

4. High-dose methotrexate in osteosarcoma: let the questions surcease-time for final acceptance;Jaffe;J Clin Oncol.,2008

5. Intensified chemotherapy with dexrazoxane cardioprotection in newly diagnosed nonmetastatic osteosarcoma: a report from the Children's Oncology Group;Schwartz;Pediatr Blood Cancer.,2016

Cited by 122 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3